| Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents A Brai, R Fazi, C Tintori, C Zamperini, F Bugli, M Sanguinetti, E Stigliano, ... Proceedings of the National Academy of Sciences 113 (19), 5388-5393, 2016 | 116 | 2016 |
| IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients E Aparicio, M Parera, S Franco, N Perez-Alvarez, C Tural, B Clotet, ... PloS one 5 (10), e13771, 2010 | 115 | 2010 |
| Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C F Puig-Basagoiti, X Forns, I Furčić, S Ampurdanes, M Gimenez-Barcons, ... Journal of general virology 86 (4), 1067-1075, 2005 | 83 | 2005 |
| Synonymous virus genome recoding as a tool to impact viral fitness MA Martínez, A Jordan-Paiz, S Franco, M Nevot Trends in microbiology 24 (2), 134-147, 2016 | 78 | 2016 |
| Early HCV dynamics on Peg-interferon and ribavirin in HIV/HCV co-infection: indications for the investigation of new treatment approaches ÁL Ballesteros, S Franco, D Fuster, R Planas, MÁ Martínez, L Acosta, ... Aids 18 (1), 59-66, 2004 | 72 | 2004 |
| Outbreak of nosocomial hepatitis C virus infection resolved by genetic analysis of HCV RNA M Bruguera, JC Saiz, S Franco, M Giménez-Barcons, JM Sánchez-Tapias, ... Journal of clinical microbiology 40 (11), 4363-4366, 2002 | 66 | 2002 |
| High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b–related cirrhosis M Giménez-Barcons, S Franco, Y Suárez, X Forns, S Ampurdanès, ... Hepatology 34 (1), 158-167, 2001 | 64 | 2001 |
| Detection of a sexually transmitted hepatitis C virus protease inhibitor-resistance variant in a human immunodeficiency virus–infected homosexual man S Franco, C Tural, M Nevot, J Moltó, JK Rockstroh, B Clotet, MA Martinez Gastroenterology 147 (3), 599-601. e1, 2014 | 62 | 2014 |
| Molecular determinants of multi-nucleoside analogue resistance in HIV-1 reverse transcriptases containing a dipeptide insertion in the fingers subdomain: effect of mutations … T Matamoros, S Franco, BM Vázquez-Alvarez, A Mas, MA Martínez, ... Journal of Biological Chemistry 279 (23), 24569-24577, 2004 | 59 | 2004 |
| Relative replication fitness of multi-nucleoside analogue-resistant HIV-1 strains bearing a dipeptide insertion in the fingers subdomain of the reverse transcriptase and … JG Prado, S Franco, T Matamoros, L Ruiz, B Clotet, L Menéndez-Arias, ... Virology 326 (1), 103-112, 2004 | 53 | 2004 |
| Therapy implications of hepatitis C virus genetic diversity MA Martinez, S Franco Viruses 13 (1), 41, 2020 | 52 | 2020 |
| Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients M de Castellarnau, E Aparicio, M Parera, S Franco, C Tural, B Clotet, ... PloS one 7 (2), e31016, 2012 | 52 | 2012 |
| Mutational patterns associated with the 69 insertion complex in multi-drug-resistant HIV-1 reverse transcriptase that confer increased excision activity and high-level … CE Cases-González, S Franco, MÁ Martínez, L Menéndez-Arias Journal of molecular biology 365 (2), 298-309, 2007 | 52 | 2007 |
| Influence of human immunodeficiency virus type 1 subtype on mother-to-child transmission N Tapia, S Franco, F Puig-Basagoiti, C Menendez, PL Alonso, H Mshinda, ... Journal of general virology 84 (3), 607-613, 2003 | 51 | 2003 |
| Influence of the genetic heterogeneity of the ISDR and PePHD regions of hepatitis C virus on the response to interferon therapy in chronic hepatitis C F Puig‐Basagoiti, JC Sáiz, X Forns, S Ampurdanès, M Giménez‐Barcons, ... Journal of medical virology 65 (1), 35-44, 2001 | 50 | 2001 |
| Impact of COVID‐19 in liver disease progression MA Martinez, S Franco Hepatology Communications 5 (7), 1138-1150, 2021 | 47 | 2021 |
| IFNL4 ss469415590 variant is a better predictor than rs12979860 of pegylated interferon-alpha/ribavirin therapy failure in hepatitis C virus/HIV-1 coinfected patients S Franco, E Aparicio, M Parera, B Clotet, C Tural, MA Martinez Aids 28 (1), 133-136, 2014 | 47 | 2014 |
| Genetic and catalytic efficiency structure of an HCV protease quasispecies S Franco, M Parera, E Aparicio, B Clotet, MA Martinez Hepatology 45 (4), 899-910, 2007 | 36 | 2007 |
| ADAR1 affects HCV infection by modulating innate immune response. BE Pujantell M, Franco S, Galván-Femenía I, Badia R, Castellví M, Garcia ... Antiviral Research 156, 116-127, 2018 | 34 | 2018 |
| Complete nucleotide sequence of genotype 4 hepatitis C viruses isolated from patients co-infected with human immunodeficiency virus type 1 S Franco, C Tural, B Clotet, MA Martínez Virus research 123 (2), 161-169, 2007 | 34 | 2007 |
